About Infervision
Infervision is a company based in Beijing (China) founded in 2016 by Shaokang Wang and Kuan Chen. Infervision has raised $212.96 million across 8 funding rounds from investors including GF Securities, European Union and Qiming Venture Partners. Infervision operates in a competitive market with competitors including Arine, HEALWELL AI, AItrics, Infermedica and Airdoc, among others.
- Headquarter Beijing, China
- Founders Shaokang Wang, Kuan Chen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$212.96 M (USD)
in 8 rounds
-
Latest Funding Round
Not available
-
Investors
GF Securities
& 18 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Infervision
Unlock access to complete
Unlock access to complete
Funding Insights of Infervision
Infervision has successfully raised a total of $212.96M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Infervision
Infervision has secured backing from 19 investors, including institutional and venture fund investors. Prominent investors backing the company include GF Securities, European Union and Qiming Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Private equity and private debt firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Early and growth-stage investments in China's TMT sector are targeted.
|
Locked | Locked | Locked |
Investor details for Infervision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Infervision
Investment portfolio details for Infervision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Infervision
Detailed financials for Infervision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Infervision Comparisons
Peer comparison for Infervision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Infervision
Infervision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Arine, HEALWELL AI, AItrics, Infermedica and Airdoc, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Patient medication intake is monitored and analyzed for healthcare professionals.
|
|
| Locked | Locked | Locked |
AI-enabled decision support tool for healthcare providers
|
|
| Locked | Locked | Locked |
AI-powered clinical decision support systems are developed for healthcare.
|
|
| Locked | Locked | Locked |
AI-powered medical diagnostic engine is developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Offers decision support solutions
|
Detailed competitors of Infervision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Infervision
Complete news archive for Infervision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Infervision
Infervision was founded in 2016.
Infervision is headquartered in Beijing, China.
Kuan Chen is the current CEO of Infervision. They have also founded this company.
Infervision is a funded company, having raised a total of $212.96M across 8 funding rounds to date.
Infervision was founded in 2016 and is headquartered in Beijing, China. Operations focus on the healthcare sector, where neural network technologies are developed for medical imaging analysis. Assistance is provided to physicians in diagnosing diseases and making treatment decisions through integrated platforms. Clinical workflows are supported for surgical planning and targeted interventions, enhancing precision in patient care.
Infervision's top competitors include Arine, Infermedica and AItrics.
Infervision has 19 investors. Key investors include GF Securities, European Union, Qiming Venture Partners, Haitong Securities, and Goldman Sachs Asset Management.